BOBYNA STEPHEN: Open Payments
NPI 1831566975 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $47 · 2025 $797
Food & beverage: $702Education: $95
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $287 |
| SOBI, INC | 4 | $136 |
| Syndax Pharmaceuticals, Inc. | 3 | $91 |
| ABBVIE INC. | 3 | $90 |
| AstraZeneca Pharmaceuticals LP | 2 | $65 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Lilly USA, LLC | 2 | $42 |
| Incyte Corporation | 1 | $29 |
Products named: Cresemba, Vonjo, EPKINLY, Xospata, CALQUENCE, JAYPIRCA, Gamifant, JAKAFI.
Industry payments across TX — which companies pay providers there.
